Skip to content
MARKETS / BALCAO / KBLB
BALCAO · PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) · SMALL CAP

Kraig Biocraft Laboratories, Inc. KBLB

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$-3.6M
$-1.8M
In brief

What this company does

Kraig Biocraft Laboratories, Inc., a Wyoming corporation, is a corporation organized to develop high strength fibers using recombinant DNA technology for commercial applications including technical textiles. We use genetically engineered silkworms that produce spider silk proteins to create our recombinant spider silk. Applications include performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics and more. Our primary proprietary fiber technology utilizes natural and engineered variants of spider silk produced in domesticated mulberry silkworms. Our recombinant spider silk fibers incorporate the silk proteins found in spider silk with native silkworm silk proteins.

Written from the business description in Kraig Biocraft Laboratories, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 30 March 2026. Every sentence was checked against that document before publication.

Growth
Revenue, FY2025 · full 19-year series below
Revenue $M Net income $M
FY2018 · Revenue 0.4 · Net income -1.2
-2.5M-5.0M2007201020132016201920222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
Operating margin Net margin
FY2018 · Operating -239.0% · Net -291.1%
-5000%2007201020132016201920222025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -1.8
-0.8M-1.6M2007201020132016201920222025

Total assetsUSD 2.6M
EquityUSD -8.0M
CashUSD 1.8M
Current ratio0.18×

Equity funds -312% of total assets.

The 19-year record
19 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B·······0.00.00.00.00.00.00.00.0····
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0···
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0···
Income tax $B·······0.00.00.00.00.00.00.00.0····
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0·−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0···
EPS, diluted $0.000.000.000.00−0.01−0.010.000.000.000.000.000.00−0.010.000.000.00···
Dividend / sh $···················
Payout %···················
ROE %···················
Shares out B······0.84··0.770.710.670.64······

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 54 reconciliationsAUDITED

Reconciled in 19 of 19 fiscal years. 22 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Listed onOTC market
Incorporated inWyoming
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2007

Share this section

Download image